US Patent Issued to IMMUNECENT BIOTECHNOLOGY, INSTITUTE OF BIOPHYSICS, CHINESE ACADEMY OF SCIENCES on May 19 for "Anti-IFNAR1 antibodies" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,639, issued on May 19, was assigned to IMMUNECENT BIOTECHNOLOGY INC. (Guangdong, China) and INSTITUTE OF BIOPHYSICS, CHINESE ACADEMY OF SCIENCES (Beijing).

"Anti-IFNAR1 antibodies" was invented by Jingyun Li (Guangdong, China), Wei Ye (Guangdong, China), Tao Liu (Guangdong, China), Xuyuan Zhang (Guangdong, China), Liguo Zhang (Guangdong, China) and Guangxia Gao (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-IFNAR1 antibodies or antigen-binding fragments thereof, isolated poly nucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof."

The patent was filed on Jan. 23, 2020...